Athersys, Inc. (ATHXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Athersys Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.5104 |
| June 30, 2023 | -0.6422 |
| March 31, 2023 | -0.2721 |
| December 31, 2022 | -0.3641 |
| September 30, 2022 | -0.539 |
| June 30, 2022 | -0.7891 |
| March 31, 2022 | 31.01 |
| December 31, 2021 | 0.5966 |
| September 30, 2021 | 0.3264 |
| June 30, 2021 | 0.3122 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0216 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.0084 |
| September 30, 2015 | 0.0107 |
| June 30, 2015 | 0.0078 |
| March 31, 2015 | 0.0097 |
| December 31, 2014 | 0.0088 |
| September 30, 2014 | 0.0067 |
| June 30, 2014 | 0.0054 |
| March 31, 2014 | 0.006 |
| December 31, 2013 | 0.0089 |
| September 30, 2013 | 0.0151 |
| June 30, 2013 | 0.0146 |
| March 31, 2013 | 0.0132 |
| December 31, 2012 | 0.0083 |
| September 30, 2012 | 0.0262 |
| June 30, 2012 | 0.0111 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |